021-65675885

• 首页
• 产品
• 化合物库
• 定制合成
• 联系我们

化合物库

Glycogen synthase kinase 3 (GSK3) inhibitor library

Glycogen synthase kinase-3 (GSK3) was initially identified more than two decades ago as an enzyme involved in the control of glycogen metabolism. In recent years it has been shown to have key roles in regulating a diverse range of cellular functions, which have prompted efforts to develop GSK3 inhibitors as therapeutics.

GSK3 inhibitors have now been shown to be effective in normalizing blood glucose levels in animal models of type 2 diabetes, with their effects seeming to occur primarily through an increase in hepatic glycogen synthesis and a decrease in hepatic gluconeogenesis.

GSK3 inhibitors might also have potential for neurodegenerative disorders, such as Alzheimer's disease. For example, there is recent evidence that GSK3 increases the production of β-amyloid — which has a key role in the pathogenesis of Alzheimer's disease — and that inhibition of GSK3 might reduce β-amyloid levels.

查看其他分子库

• • Fragment-based library>>
  • 4532种片段化合物库，可用于高通量筛选和高内涵筛选。
• • Anti-cancer clinical drug library>>
  • 1813个上市药物化合物集合，可用于高通量筛选和高内涵筛选。
• • GASC1 Targeted Library>>
  • 966种GASC1抑制化合物集合，用于筛选新型GASC1抑制剂。
• • EZH2 Targeted Library>>
  • 979种EZH2抑制化合物集合，可用于抗肿瘤治疗药物发现研究
• • Catechol O Methyl Transferase Targeted Library>>
  • 504种COMT抑制化合物集合，用于神经和神经精神疾病相关的药物发现研究。
• • Cathepsin K Targeted Library>>
  • 761种Cathepsin K 抑制化合物集合，可用于Cathepsin K异常功能导致的病理相关药物发现研究。
• • PDZ Domain Targeted Library>>
  • 可用于PDZ领域相关的药物发现项目.
• • Glycogen synthase kinase 3 (GSK3) inhibitor library>>
  • 479种GSK3抑制剂化合物集合，可用于GSK3抑制剂药物研发领域。